Bone edema determined by magnetic resonance imaging reflects severe disease status in patients with early-stage rheumatoid arthritis

Journal of Rheumatology

Volumn 34, Issue 11, 2007, Pages 2154-2157

  Tamai, Mami ^a   Kawakami, Atsushi ^a   Uetani, Masataka ^a   Takao, Shoichiro ^a   Tanaka, Fumiko ^a   Fujikawa, Keita ^a   Aramaki, Toshiyuki ^a   Nakamura, Hideki ^a   Iwanaga, Nozomi ^a   Izumi, Yasumori ^a   Arima, Kazuhiko ^a   Aratake, Kouichiro ^a   Kamachi, Makoto ^a   Huang, Mingguo ^a   Origuchi, Tomoki ^a   Ida, Hiroaki ^a   Aoyagi, Kiyoshi ^a   Eguchi, Katsumi ^a  

^a NAGASAKI UNIVERSITY   (Japan)

Author keywords

Bone edema; Early stage rheumatoid arthritis; HLA DRB1*0405 allele; Magnetic resonance imaging; Serologic variables

Indexed keywords

C REACTIVE PROTEIN; HLA DR ANTIGEN; INTERLEUKIN 6; PEPTIDE ANTIBODY; STROMELYSIN;

ANTIBODY TITER; ARTICLE; BONE EDEMA; BONE EROSION; CONTROLLED STUDY; DISEASE ACTIVITY; DISEASE SEVERITY; EDEMA; HUMAN; MAJOR CLINICAL STUDY; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RHEUMATOID ARTHRITIS; SEROLOGY; SYNOVITIS;

ARTHRITIS, RHEUMATOID; AUTOANTIBODIES; BONE AND BONES; C-REACTIVE PROTEIN; EDEMA; HLA-DR ANTIGENS; HUMANS; INTERLEUKIN-6; MAGNETIC RESONANCE IMAGING; MATRIX METALLOPROTEINASE 3; PEPTIDES, CYCLIC; PROGNOSIS; SYNOVITIS;

EID: 35948984155     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. Lassere M, McQueen F, Ostergaard M, et al. OMERACT rheumatoid arthritis magnetic resonance imaging studies. Exercise 3: An international multicenter reliability study using the RA-MRI score. J Rheumatol 2003;30:1366-75.
2. Conaghan P, Lassere M, Ostergaard M, et al. OMERACT rheumatoid arthritis magnetic resonance imaging studies. Exercise 4: An international multicenter longitudinal study using the RA-MRI score. J Rheumatol 2003;30:1376-9.
3. McQueen FM, Beneton N, Perry D, et al. Bone edema scored on magnetic resonance imaging scans of the hands and feet six years later in patients with rheumatoid arthritis. Arthritis Rheum 2003;48:1814-27.
4. Conaghan PG, O'Connor P, McGonagle D, Astin P, et al. Elucidation of the relationship between synovitis and bone damage: A randomized magnetic resonance imaging study of individual joints in patients with early rheumatoid arthritis. Arthritis Rheum 2003;48:64-71.
5. Tamai M, Kawakami A, Uetani M, et al. The presence of anti-cyclic citrullinated peptide antibody is associated with MRI detection of bone marrow oedema in early-stage rheumatoid arthritis. Ann Rheum Dis 2006;65:133-4.
6. Tamai M, Kawakami A, Uetani M, et al. Early prediction of rheumatoid arthritis by serologic variables and magnetic resonance imaging of the wrists and finger joints: Results from prospective clinical examination. Ann Rheum Dis 2006;65:134-5.
7. van Gaalen FA, van Aken J, Huizinga TW, et al. Association between HLA class II genes and autoantibodies to cyclic citrullinated peptides (CCPs) influences the severity of rheumatoid arthritis. Arthritis Rheum 2004;50:2113-21.
8. Arnett EC, Edworthy SM, Bloch DA, et al. The American Rheumatology Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988;31:315-24.
9. Shibue T, Tsuchiya N, Komata T, et al. Tumor necrosis factor alpha 5′-flanking region, tumor necrosis factor receptor II, and HLA-DRB1 polymorphisms in Japanese patients with rheumatoid arthritis. Arthritis Rheum 2000;43:753-7.
10. McQueen FM. Magnetic resonance imaging in early inflammatory arthritis: what is its role? Rheumatology Oxford 2000;39:700-6.